Summary
Industry
Insights
Lindus Health, based in London, aims to transform the clinical trials landscape with its specialized software platform. Utilizing a B2B SaaS model, Lindus Health seeks to streamline and optimize the traditionally cumbersome process of conducting clinical trials, often hindered by disconnected platforms and manual methods. The company helps reduce development delays, lower costs, and accelerate time-to-market for new treatments. With backing from investors like Valar Ventures and Atomico, Lindus Health is poised to disrupt the biotech and health tech industries by addressing key pain points in drug development.
Investors
Atomico Seed
Calm/Storm Ventures Seed
Firstminute Capital Seed
Hambro Perks Ltd. Seed
Seedcamp Seed
Valar Ventures Seed
Creandum Series A